| 中文名 | 4-氧代-1,4-二氢-1,7-萘啶-3-羧酸乙酯 |
|---|---|
| 英文名 | ethyl 4-oxo-1H-1,7-naphthyridine-3-carboxylate |
| 英文别名 |
1,5-Naphthyridine-3-carboxylic acid, 4-hydroxy-, ethyl ester
1,4-Dihydro-4-oxo-1,7-naphthyridine-3-carboxylic acid ethyl ester Ethyl 4-Hydroxy-1,5-naphthyridine-3-carboxylate |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 345.7±37.0 °C at 760 mmHg |
| 分子式 | C11H10N2O3 |
| 分子量 | 218.209 |
| 闪点 | 162.8±26.5 °C |
| 精确质量 | 218.069138 |
| PSA | 72.05000 |
| LogP | 2.87 |
| 蒸汽压 | 0.0±0.8 mmHg at 25°C |
| 折射率 | 1.639 |
|
~%
862546-07-4 |
| 文献:VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2009/36412 A1, 2009 ; Location in patent: Page/Page column 64-65 ; WO 2009/036412 A1 |
| 上游产品 1 | |
|---|---|
| 下游产品 1 | |